Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Seclin, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Alzheimer's disease are exploring potential therapeutic interventions using natural compounds. These studies aim to evaluate the impact of commonly consumed substances on cognitive function in patients with early to moderate stages of the condition.
This research investigates the potential of caffeine treatment as a therapeutic intervention, examining its effects on cognitive decline over an extended period. The controlled trial design ensures reliable evaluation of treatment efficacy in patients with varying degrees of cognitive impairment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
